Endoscopy 2022; 54(S 01): S239-S240
DOI: 10.1055/s-0042-1745256
Abstracts | ESGE Days 2022
ESGE Days 2022 Digital poster exhibition

DESMOPLASTIC STROMA IDENTIFICATION AS A QUALITY MARKER FOR RELIABLE HISTOLOGIC SAMPLES OBTAINED BY EUS IN SOLID PANCREATIC LESIONS. A NEW STANDARD FOR ADEQUACY

G. Perez Alvarez
1   Hospital Universitario San Agustin, Gastroenterology, Aviles, Spain
,
I. Husain Calzada
2   Hospital Universitario San Agustin, Pathology, Aviles, Spain
,
C.A. Vargas Gonzalez
1   Hospital Universitario San Agustin, Gastroenterology, Aviles, Spain
,
F.X. Cano Calderero
1   Hospital Universitario San Agustin, Gastroenterology, Aviles, Spain
,
E. Junquera Alonso
1   Hospital Universitario San Agustin, Gastroenterology, Aviles, Spain
,
M. Terroba Alonso
1   Hospital Universitario San Agustin, Gastroenterology, Aviles, Spain
,
C. Cerrella Cano
1   Hospital Universitario San Agustin, Gastroenterology, Aviles, Spain
,
J. Alonso de la Campa
2   Hospital Universitario San Agustin, Pathology, Aviles, Spain
,
G. Meijide Santos
2   Hospital Universitario San Agustin, Pathology, Aviles, Spain
,
L. Perez Vidal
2   Hospital Universitario San Agustin, Pathology, Aviles, Spain
,
M. Crespo Sanchez
2   Hospital Universitario San Agustin, Pathology, Aviles, Spain
,
L. Sanchez Dominguez
2   Hospital Universitario San Agustin, Pathology, Aviles, Spain
› Author Affiliations
 

Aims To evaluate the presence of desmoplastic stroma as a potential new quality marker of the fine needle biopsy (FNB) samples in pancreatic ducal adenocarcinoma (PDAC). To illustrate that a simplified strategy to obtain and process the tissue using histologic needles allows an adequate high-quality sample, including the identification of stroma.

Methods We retrospectively analyzed the global diagnostic performance and the presence of desmoplastic stroma in consecutive FNB samples of solid pancreatic lesions clinically suspicious of PDAC. We included those lesions starting after the switch from cytologic-based (FNA) samples to those obtained using histologic needles (FNB), and processed straightforwardly as a usual biopsy, what we defined as “simplified biopsy”, namely to directly express the tissue in formalin, doing a rapid first adequacy assessment according to macroscopic on-site evaluation (MOSE) as described in the literature. 22G caliber Franseen and fork-type needles were used.

Results

Table 1

ANALYSED VARIABLE

FREQUENCY: Mode (n)

Tip design

Franseen 22G (14)

Number of passes

3 (9), range 2-4

Adequacy to diagnose PDAC

YES: 100% (15)

Visible desmoplastic stroma

YES: 100% (15)

From January 2020 to August 2021, fifteen consecutive purely solid and 5 solid-cystic lesions were diagnosed as PDAC using the simplified biopsy strategy. Diagnostic accuracy was 100%. Desmoplastic stroma was identified in all the samples from solid lesions.

Zoom Image
Fig. 1

Conclusions Identification of desmoplastic stroma could work as a new specific quality marker for FNB samples, as it represents a more reliable feature of a PDAC lesion in terms of molecular microenvironment. This could facilitate ancillary tests aimed at stromal therapeutic targets including the design of organoids. A simplified biopsy strategy allows to easily obtain high quality histologic specimens with a complete diagnostic yield.



Publication History

Article published online:
14 April 2022

© 2022. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany